Pareek Puneet, Vishnoi Jeewan Ram, Kombathula Sri Harsha, Vyas Rakesh Kumar, Misra Sanjeev
Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India.
Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India.
JCO Glob Oncol. 2020 Sep;6:1455-1460. doi: 10.1200/GO.20.00295.
The core pillars of multimodal care of patients with cancer are surgical, radiation, and medical oncology. The global pandemic of coronavirus disease 2019 (COVID-19) has suddenly resurrected a new pillar in oncology care: teleoncology. With oncologists reaching out to patients through telemedicine, it is possible to evaluate and fulfill patients' needs; triage patients for elective procedures; screen them for influenza-like illness; provide them with guidance for hospital visits, if needed; and bridge oral medications and treatments when a hospital visit is not desirable because of any high risk-benefit ratio. Teleoncology can bring great reassurance to patients at times when reaching an oncology center is challenging, and more so in resource-constrained countries. Evidence-based treatment protocols, dispensable by teleoncology, already exist for many sites of cancer and they can provide a bridge to treatment when patients are unable to reach cancer centers for their standard treatment. The young pillar of teleoncology is going to remain much longer than COVID-19.
癌症患者多模式护理的核心支柱是外科肿瘤学、放射肿瘤学和医学肿瘤学。2019年冠状病毒病(COVID-19)的全球大流行突然在肿瘤护理中催生了一个新支柱:远程肿瘤学。通过远程医疗,肿瘤学家能够与患者取得联系,进而评估并满足患者需求;对患者进行分流以便安排择期手术;为他们筛查流感样疾病;如有必要,为他们提供就诊指导;当因任何高风险效益比而不适合就诊时,还能衔接口服药物和治疗。在前往肿瘤中心具有挑战性的时候,远程肿瘤学能给患者带来极大的安慰,在资源有限的国家更是如此。远程肿瘤学可以采用的循证治疗方案已经存在于许多癌症部位,当患者无法前往癌症中心接受标准治疗时,这些方案可以为治疗提供桥梁。远程肿瘤学这个年轻的支柱将比COVID-19存在的时间长得多。